EW Edwards Lifesciences Corporation
$86.29
Edwards Lifesciences Corporation (EW) is expected to report earnings on October 26, 2026, after the market close. The consensus earnings estimate is $0.73 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -1.9% since its last earnings release on July 23, 2026.
Edwards Lifesciences Beat Expectations, Narrows Revenue Guidance
Thursday, July 23, 2026 · 4:15 PM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 26
Monday · 4:15 PM ET
Earnings Whisper
-
vs $0.73
Rev est $1.68B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$88.16
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Edwards Lifesciences Corporation
Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring.
Sector
Healthcare
Industry
Medical Instruments/Supply
Held By 10 ETFs, by dollar flow
- IYH iShares U.S. Healthcare ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- IXJ iShares Global Healthcare ETF
- BMED iShares Health Innovation Active ETF
- BMED iShares Health Innovation Active ETF
- IHI iShares U.S. Medical Devices ETF
- IHI iShares U.S. Medical Devices ETF
Charts powered in part by Lightweight Charts™ by TradingView.